Midatech Pharma PLC Probability of Future Stock Price Finishing Under 0.7163

MTPDelisted Stock  USD 1.14  0.26  18.57%   
Midatech Pharma's future price is the expected price of Midatech Pharma instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Midatech Pharma PLC performance during a given time horizon utilizing its historical volatility. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
  
Please specify Midatech Pharma's target price for which you would like Midatech Pharma odds to be computed.

Midatech Pharma Target Price Odds to finish below 0.7163

The tendency of Midatech Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to drop to $ 0.72  or more in 90 days
 1.14 90 days 0.72 
about 51.58
Based on a normal probability distribution, the odds of Midatech Pharma to drop to $ 0.72  or more in 90 days from now is about 51.58 (This Midatech Pharma PLC probability density function shows the probability of Midatech Stock to fall within a particular range of prices over 90 days) . Probability of Midatech Pharma PLC price to stay between $ 0.72  and its current price of $1.14 at the end of the 90-day period is about 44.68 .
Considering the 90-day investment horizon Midatech Pharma PLC has a beta of -2.56. This indicates as returns on its benchmark rise, returns on holding Midatech Pharma PLC are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Midatech Pharma is expected to outperform its benchmark. In addition to that Midatech Pharma PLC has an alpha of 2.9166, implying that it can generate a 2.92 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
   Midatech Pharma Price Density   
       Price  

Predictive Modules for Midatech Pharma

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Midatech Pharma PLC. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Midatech Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
1.141.141.14
Details
Intrinsic
Valuation
LowRealHigh
0.860.861.25
Details
Naive
Forecast
LowNextHigh
1.761.761.76
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.981.231.47
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Midatech Pharma. Your research has to be compared to or analyzed against Midatech Pharma's peers to derive any actionable benefits. When done correctly, Midatech Pharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Midatech Pharma PLC.

Midatech Pharma Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Midatech Pharma is not an exception. The market had few large corrections towards the Midatech Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Midatech Pharma PLC, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Midatech Pharma within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
2.92
β
Beta against NYSE Composite-2.56
σ
Overall volatility
0.24
Ir
Information ratio 0.08

Midatech Pharma Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Midatech Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Midatech Pharma PLC can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Midatech Pharma PLC is not yet fully synchronised with the market data
Midatech Pharma PLC may become a speculative penny stock
Midatech Pharma PLC has a very high chance of going through financial distress in the upcoming years
The company reported the last year's revenue of 578 K. Reported Net Loss for the year was (5.46 M) with profit before taxes, overhead, and interest of 578 K.
Midatech Pharma PLC has about 6.42 M in cash with (6.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.63, which can makes it an attractive takeover target, given it will continue generating positive cash flow.

Midatech Pharma Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Midatech Stock often depends not only on the future outlook of the current and potential Midatech Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Midatech Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding3.2 M
Cash And Short Term Investments10.1 M

Midatech Pharma Technical Analysis

Midatech Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. Midatech Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Midatech Pharma PLC. In general, you should focus on analyzing Midatech Stock price patterns and their correlations with different microeconomic environments and drivers.

Midatech Pharma Predictive Forecast Models

Midatech Pharma's time-series forecasting models is one of many Midatech Pharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Midatech Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Midatech Pharma PLC

Checking the ongoing alerts about Midatech Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Midatech Pharma PLC help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Midatech Pharma PLC is not yet fully synchronised with the market data
Midatech Pharma PLC may become a speculative penny stock
Midatech Pharma PLC has a very high chance of going through financial distress in the upcoming years
The company reported the last year's revenue of 578 K. Reported Net Loss for the year was (5.46 M) with profit before taxes, overhead, and interest of 578 K.
Midatech Pharma PLC has about 6.42 M in cash with (6.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.63, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Consideration for investing in Midatech Stock

If you are still planning to invest in Midatech Pharma PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Midatech Pharma's history and understand the potential risks before investing.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes